Panagora Asset Management Inc Veracyte, Inc. Transaction History

Panagora Asset Management Inc

$21 Billion
Q4 2024

A detailed history of Panagora Asset Management Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 205,933 shares of VCYT stock, worth $8.47 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

205,933

Previous 101,430 103.03%

Holding current value

$8.47 Million

Previous $3.45 Million 136.28%

% of portfolio

0.04%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$31.92 - $44.4 $3.34 Million - $4.64 Million	104,503 Added 103.03%	205,933 $8.15 Million
Q3 2024 Nov 13, 2024	BUY	$21.0 - $35.25 $2.13 Million - $3.58 Million	101,430 New	101,430 $3.45 Million
Q1 2023 May 11, 2023	BUY	$20.58 - $27.89 $7,717 - $10,458	375 Added 1.46%	26,004 $579,000
Q4 2022 Feb 13, 2023	SELL	$15.31 - $29.94 $94,278 - $184,370	-6,158 Reduced 19.37%	25,629 $608,000
Q2 2022 Aug 15, 2022	BUY	$15.45 - $29.52 $248,111 - $474,061	16,059 Added 102.1%	31,787 $633,000
Q3 2021 Nov 10, 2021	SELL	$35.62 - $52.97 $1.52 Million - $2.27 Million	-42,781 Reduced 73.12%	15,728 $731,000
Q2 2021 Aug 11, 2021	SELL	$32.94 - $56.62 $1.57 Million - $2.7 Million	-47,644 Reduced 44.88%	58,509 $2.34 Million
Q1 2021 May 12, 2021	BUY	$44.47 - $81.38 $3.82 Million - $6.99 Million	85,868 Added 423.31%	106,153 $5.71 Million
Q3 2020 Nov 13, 2020	SELL	$26.73 - $35.67 $489,399 - $653,082	-18,309 Reduced 47.44%	20,285 $659,000
Q2 2020 Aug 12, 2020	SELL	$19.49 - $28.11 $1,695 - $2,445	-87 Reduced 0.22%	38,594 $1 Million
Q1 2020 May 14, 2020	BUY	$16.13 - $30.17 $62,052 - $116,063	3,847 Added 11.04%	38,681 $940,000
Q4 2019 Feb 12, 2020	BUY	$20.78 - $29.99 $15,668 - $22,612	754 Added 2.21%	34,834 $973,000
Q3 2019 Nov 12, 2019	BUY	$23.87 - $30.93 $162,650 - $210,757	6,814 Added 24.99%	34,080 $818,000
Q2 2019 Aug 09, 2019	BUY	$22.1 - $28.56 $223,165 - $288,398	10,098 Added 58.82%	27,266 $777,000
Q1 2019 May 15, 2019	SELL	$12.0 - $25.76 $1.6 Million - $3.45 Million	-133,746 Reduced 88.62%	17,168 $430,000
Q4 2018 Feb 14, 2019	SELL	$9.15 - $14.85 $307,604 - $499,227	-33,618 Reduced 18.22%	150,914 $1.9 Million
Q3 2018 Nov 13, 2018	SELL	$9.55 - $12.64 $221,922 - $293,728	-23,238 Reduced 11.18%	184,532 $1.76 Million
Q2 2018 Aug 14, 2018	SELL	$5.39 - $9.66 $5,939 - $10,645	-1,102 Reduced 0.53%	207,770 $1.94 Million
Q1 2018 May 15, 2018	BUY	$5.44 - $6.97 $112,771 - $144,488	20,730 Added 11.02%	208,872 $1.16 Million
Q4 2017 Feb 14, 2018	BUY	$6.05 - $9.37 $480,176 - $743,678	79,368 Added 72.97%	188,142 $1.23 Million
Q3 2017 Nov 14, 2017	BUY	$7.81 - $8.77 $849,524 - $953,947	108,774	108,774 $954,000

Others Institutions Holding VCYT

# of Institutions

336

Shares Held

81.1M

Call Options Held

202K

Put Options Held

18.6K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.94B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Veracyte, Inc. Transaction History